Home
LEO Pharma

LEO Pharma Market Share Analysis for June 2026

Health > Biotechnology and Pharmaceuticals

Domainleo-pharma.us

Year Founded1908

Employees1001 - 5000

Annual Revenue> $1B

LEO Pharma

LEO Pharma (including company regionals)

leo-pharma.us

See more website traffic and engagement information

LEO Pharma Revenue up to June 2026 is > 1B

revenue generated by LEO Pharma top domains

LEO Pharma top domains revenue over 3 years

Revenue for LEO Pharma top domains

leo-pharma.us> 1B

See more with Sales Intelligence

Total visits to LEO Pharma's top domains

Understand LEO Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

leo-pharma.us9.2K

See more with Sales Intelligence

Avg. visit duration in LEO Pharma's top domains

Analyze LEO Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

leo-pharma.us00:01:59

See more with Sales Intelligence

Avg. pageviews on LEO Pharma's top domains

See how LEO Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

leo-pharma.us1.90

See more with Sales Intelligence

LEO Pharma top competitors by domain

Top similar sites in June 2026, ranked by their affinity

psoriasis.orgCompany NameNational Psoriasis FoundationEmployees51 - 200HQUnited States, Oregon, PortlandAnnual revenue$10M - $15MTotal visits310.2KHealth > Health Conditions and Concerns

Top technologies used by LEO Pharma

These are the website technologies, by industry, used by LEO Pharma top domains

Advertising (3)

DoubleClick

Mobile (3)

Meta Viewport

Audio Video Media (1)

YouTube

Content Management System (1)

Sitecore CMS

More Technologies

6

See all

News & Signals from LEO Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLEO Pharma Inc. is developing programs for inflammatory diseases by reuters.Gilead, LEO Pharma partner to develop programs for inflammatory diseases by reuters.

NewsLEO Pharma Inc. is developing potential topical formulations of STAT6 inhibitors.Gilead will spearhead additional development efforts for the oral programs, while LEO Pharma will focus on developing potential topical formulations of STAT6 inhibitors.

NewsLEO Pharma Inc. launches Anzupgo cream in Germany.Danish dermatology focused LEO Pharma has announced the launch of Anzupgo (delgocitinib) cream in Germany for the treatment of adult patients with moderate to severe chronic hand eczema (CHE), for whom topical corticosteroids are inadequate or inappropriate.